Inventor
Piet Herdewijn
Inventor
Wezemaal, BE
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Hprimary
C07HSugars22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium12%
A61KPreparations for medical, dental or toiletry purposes10%
C07DHeterocyclic compounds10%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
Y02ATechnologies for adaptation to climate change4%
B82YSpecific uses or applications of nanostructures2%
PatentTitleYear
11,040,047Prodrugs of nucleoside phosphonates202110,087,209Antiviral compounds, a process for their preparation, and their use for treating viral infections20189,522,932'Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production'20169,249,177'Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production'20169,139,572'Compounds, methods, complexes, apparatuses and uses relating to stabile forms of NAD/NADH'20158,809,520'Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production'20148,758,688'Microelectronic structures for patterned deposition of molecules onto surfaces'20148,501,709'Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production'20138,242,087'Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents'20128,076,310'Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production'20117,553,615'Compounds, methods, complexes, apparatuses and uses relating to stabile forms of NAD/NADH'20097,276,592'Nucleotide analogs with six-membered rings'20077,049,332'HIV inhibiting N-aminoimidazole derivatives'20065,607,922'1,5-anhydrohexitol nucleoside analogues'19975,116,822'Therapeutic application of dideoxycytidinene'19924,963,533'Therapeutic application of dideoxycytidinene'1990Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1990–1992Based in Kessel-Lo, BE· patent location history
1992–1997Patents assigned to STICHTING REGA V Z W (2)· patent assignee history
1997–2015Based in Rotselaar, BE· patent location history
2006–2016Patents assigned to LEUVEN K U RES & DEV (7)· patent assignee history
2006–2016Based in Wezemaal, BE· patent location history
2007–2015Patents assigned to ROCHE DIAGNOSTICS OPERATIONS (3)· patent assignee history
2011–2015Patents assigned to HERDEWIJN PIET (5)· patent assignee history
2011–2013Patents assigned to PANNECOUQUE CHRISTOPHE (2)· patent assignee history
2018–2021Based in Heverlee, BE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LEUVEN K U RES & DEV | 7 | 2006–2016 |
| HERDEWIJN PIETself | 5 | 2011–2015 |
| ROCHE DIAGNOSTICS OPERATIONS | 3 | 2007–2015 |
| PANNECOUQUE CHRISTOPHE | 2 | 2011–2013 |
| STICHTING REGA V Z W | 2 | 1992–1997 |
Locations
| Location | Patents | Span |
|---|---|---|
| Wezemaal, BE | 9 | 2006–2016 |
| Rotselaar, BE | 3 | 1997–2015 |
| Heverlee, BE | 2 | 2018–2021 |
| Kessel-Lo, BE | 2 | 1990–1992 |